Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Specific Pharma A/S
A/S
Active
CVR 33161395
Borgmester Christiansens Gade 40, 2450
København SV
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2010 · 15 years old
40 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Specific Pharma A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
273M
205M
136M
68M
0M
2022: 123M
123M
2022
2023: 178M (+45% vs 2022)
178M
+45%
2023
2024: 211M (+19% vs 2023)
211M
+19%
2024
2025: 219M (+4% vs 2024)
219M
+4%
2025
2026: 158M (-28% vs 2025)
158M
-28%
2026
EBITDA
DKK millions
46M
35M
23M
12M
0M
2022: 10M
10M
2022
2023: 17M (+70% vs 2022)
17M
+70%
2023
2024: 29M (+71% vs 2023)
29M
+71%
2024
2025: 37M (+28% vs 2024)
37M
+28%
2025
2026: 15M (-59% vs 2025)
15M
-59%
2026
Income statement
DKK thousands
Item
2026
2025
2024
2023
2022
Revenue
157.797
219.329
210.987
177.609
123.270
Staff expenses
-22.860
-20.739
-19.602
-17.328
-15.900
EBITDA
15.322
36.536
28.945
17.411
10.482
Depreciation & amort.
-131
-133
-166
-739
-868
EBIT
15.191
36.403
28.779
16.672
9.614
Net financials
4.294
1.091
3.998
-4.005
354
Profit before tax
19.485
37.494
32.777
12.667
9.968
Tax
4.293
8.255
7.217
2.791
2.199
Net profit
15.192
29.239
25.560
9.876
7.769
Balance sheet
DKK thousands
Item
2026
2025
2024
2023
2022
Total assets
115.179
134.475
126.169
104.981
103.079
Equity
98.645
111.203
106.245
89.564
85.488
Long-term debt
0
127
198
98
1.742
Short-term debt
16.534
23.108
19.709
15.311
15.845
Total debt
16.534
23.235
19.907
15.409
17.587
Financial ratios
5-year trend
EBITDA margin
9,7 %
This company
15,8 %
Market median
This company
Market median
39% below market
2022
2026
Equity ratio
85,6 %
This company
38,2 %
Market median
This company
Market median
124% above market
2022
2026
Return on equity
15,4 %
This company
18,4 %
Market median
This company
Market median
16% below market
2022
2026
Net profit margin
9,6 %
This company
8,1 %
Market median
This company
Market median
19% above market
2022
2026
Asset turnover
1,37×
This company
1,12×
Market median
This company
Market median
22% above market
2022
2026
Debt / equity
0,17×
This company
0,62×
Market median
This company
Market median
73% below market
2022
2026
Annual reports & filings
Annual report 2026
Filed via CVR / Virk · Period 2025-02-01 – 2026-01-31
View
PDF
Annual report 2025
Filed via CVR / Virk · Period 2024-02-01 – 2025-01-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-02-01 – 2024-01-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-02-01 – 2023-01-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-02-01 – 2022-01-31
View
PDF
More on Specific Pharma A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
